High-Level Overview
Aluna is a biomedical AI company focused on respiratory health management, providing an AI-enabled platform that combines a portable, FDA-cleared spirometer with a mobile app to monitor lung function and manage chronic respiratory diseases such as asthma, COPD, and cystic fibrosis. The platform serves patients, caregivers, and healthcare providers by enabling daily lung health monitoring, symptom tracking, medication adherence, and environmental factor logging, with proprietary machine learning algorithms that help clinicians identify respiratory issues early and intervene to prevent exacerbations. Aluna’s solution addresses the problem of infrequent and reactive respiratory care by enabling continuous, remote patient monitoring, improving clinical outcomes and reducing costly hospital visits. The company has demonstrated strong growth momentum, recently closing a $15.3 million Series B funding round to expand its product reach and enhance its offerings[2][4].
Origin Story
Founded in 2013 in the San Francisco Bay Area by three asthmatics who met at the University of California, Berkeley, Aluna’s origins are deeply rooted in personal experience with respiratory disease. The founders’ shared challenges with asthma inspired them to create a technology-driven solution that brings clarity and peace of mind to patients and clinicians managing chronic respiratory conditions. Early traction came from close collaboration with leading academic medical centers and physicians, ensuring the platform’s safety, efficacy, and integration into existing treatment plans. The company has been recognized by the National Science Foundation and has steadily grown its funding base, reflecting confidence in its mission and technology[2][3][4].
Core Differentiators
- Product Differentiators: Aluna offers an FDA-cleared portable spirometer paired with a mobile app that gamifies spirometry to encourage proper technique and daily use, enhancing patient engagement and adherence.
- Developer Experience: The platform integrates proprietary machine learning algorithms that analyze patient-generated data alongside clinical inputs to provide actionable insights to healthcare providers.
- Speed, Pricing, Ease of Use: The device and app enable real-time data transmission and remote patient monitoring, eligible for insurance coverage, facilitating early intervention and reducing healthcare costs.
- Community Ecosystem: Developed in consultation with top physicians and adopted by allergists and pulmonologists, Aluna fosters a collaborative ecosystem between patients, caregivers, and medical professionals to improve respiratory care[2][4].
Role in the Broader Tech Landscape
Aluna rides the growing trend of digital health and remote patient monitoring, particularly accelerated by the need for continuous chronic disease management outside traditional clinical settings. The timing is critical as healthcare systems increasingly adopt AI and connected devices to improve patient outcomes and reduce costs. Market forces such as rising prevalence of respiratory diseases, advances in AI, and regulatory support for remote monitoring create a favorable environment for Aluna’s growth. By enabling daily lung function monitoring and data-driven clinical decision-making, Aluna influences the broader ecosystem by demonstrating how AI-powered tools can transform chronic disease management and patient engagement[2][4].
Quick Take & Future Outlook
Looking ahead, Aluna is positioned to expand its product line, increase spirometer production, and deepen its AI capabilities to revolutionize respiratory care further. Trends such as personalized medicine, integration of environmental data, and broader adoption of remote monitoring will shape its journey. As Aluna scales, its influence may extend beyond respiratory health into other biomedical AI applications, leveraging its data-driven approach to improve clinical outcomes. The company’s mission to empower patients and clinicians with actionable lung health data ties back to its founding vision of transforming respiratory disease management through technology and collaboration[4][2].
